• 
• 
• 
• 

FDA News and Drug Updates

November 11, 2019 — Oncology News & Updates

FDA News

Nubeqa New Oral Therapy FDA Approved for Nonmetastatic Prostate Cancer

Turalio First FDA-Approved Systemic Therapy for Tenosynovial Giant-Cell Tumor

Side-Effects Management

NCCN Issues First Guideline for Immunotherapy-Related Adverse Events

Wayne Kuznar

Suboptimal Dosing of Filgrastim Is Acceptable for Treatment of Chemotherapy-Induced Neutropenia

Audrey Andrews

Understanding Immunotherapy Late Adverse Effects in Cancer Survivors

Meg Barbor, MPH

Immunotherapy Combination Shows Promising Results in HER2 1+/2+ Breast Cancer

Discontinuing Immunotherapy Because of Adverse Effects May Not Compromise Efficacy

Phoebe Starr

View All Side-Effects Management Articles

Immunotherapy

CAR T-Cell Therapy Targeting Solid Tumors

Chase Doyle

CAR T-Cell Therapy Fills Unmet Needs in Leukemia and Lymphoma

Wayne Kuznar

Genomic Markers of Response Improve Patient Selection for Immune Checkpoint Inhibitor Therapy

Wayne Kuznar

CAR T-Cell Therapy Associated with Unique, Acute Adverse Events Requiring Vigilant Monitoring

Wayne Kuznar

Adding Immunotherapy to Chemotherapy Extends Survival in Metastatic Triple-Negative Breast Cancer

Phoebe Starr

View All Immunotherapy Articles

Conference Correspondent

Centers for Disease Control and Prevention Guidelines on Opioid Use for Cancer Pain

Maintenance Chemotherapy After Hematopoietic Stem-Cell Transplantation

Graft-versus-Host Disease: Breakthroughs on the Horizon

Basket Clinical Trials: A New Era in Cancer Treatment

Burnout Rates High for Pharmacists in Hematopoietic Stem-Cell Transplantation

Chemotherapy Treatment Considerations in Special Patient Populations

Nivolumab/Ipilimumab Combination Extends Survival for Patients with Melanoma

View All Conference Correspondent Articles

Most Popular Articles

FDA on In Vitro Diagnostics, Vaping; Cost of Novel Treatments

Web Exclusives - FDA Updates, In the News, NCCN

Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News

Web Exclusives - Breast Cancer, FDA Updates, In the News, Multiple Myeloma, Pediatric Cancer

October 28, 2019 – Oncology News & Updates

Web Exclusives - FDA Updates, In the News, Ovarian Cancer

Adding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of Care

Phoebe Starr

Web Exclusives - ESMO, Breast Cancer

Nubeqa New Oral Therapy FDA Approved for Nonmetastatic Prostate Cancer

Web Exclusives - FDA Updates